Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $309.6300 (2.41%) ($0.0000 - $0.0000) on Thu. Aug. 8, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.72% (three month average) | RSI | 59 | Latest Price | $309.6300(2.41%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | REGN declines -0.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(58%) XLV(47%) IVW(41%) IWF(40%) QQQ(40%) | Factors Impacting REGN price | REGN will decline at least -0.86% in a week (0% probabilities). VIXM(-24%) VXX(-11%) IFRA(-7%) TLT(-6%) TIP(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.86% (StdDev 1.72%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $303.51(2.02%) | 10 Day Moving Average | $305.73(1.28%) | 20 Day Moving Average | $303.71(1.95%) | To recent high | -5.9% | To recent low | 6.1% | Market Cap | $32.83b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |